Albert R. Collinson

Albert R. Collinson, Ph.D. is a seasoned executive in the pharmaceutical and biotechnology sectors with extensive leadership experience. Currently serving on the Board of Directors at Privo Technologies Inc and HARBOUR BIOMED, as well as an advisor to TheracosBio, Collinson has a history of impactful roles including President and CEO of TheracosBio and Opsonic Therapeutics, and Chief Business Officer at Rib-X Pharmaceuticals. Collinson’s career also includes significant positions in business development and licensing at Phylos, Inc. and BASF Pharmaceuticals, and a foundational role as a scientist at ImmunoGen, Inc. Collinson holds a Ph.D. in Biochemistry from Brandeis University and dual Bachelor of Science degrees from the University of Rhode Island and the University of Hawaii at Manoa.